Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,317 | -38,700 | -24,123 | -12,263 | -55,189 |
| Depreciation Amortization | 3,192 | 2,469 | 1,641 | 818 | 3,200 |
| Accounts payable and accrued liabilities | 667 | 1,509 | 852 | 825 | -3,607 |
| Other Working Capital | -4,023 | 226 | -1,401 | -2,563 | -2,695 |
| Other Operating Activity | -14,941 | 46 | 149 | -372 | 5,467 |
| Operating Cash Flow | $-51,422 | $-34,450 | $-22,882 | $-13,555 | $-52,824 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -321 | -193 | -111 | -29 | -2,230 |
| Sale Of Investment | 5,000 | 0 | N/A | 0 | N/A |
| Other Investing Activity | 20,958 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $25,637 | $-193 | $-111 | $-29 | $-2,230 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 92,343 | N/A | N/A | N/A | N/A |
| Debt Repayment | -29 | -21 | -11 | -5 | -1 |
| Common Stock Issued | 168 | 167 | 132 | 112 | 73 |
| Other Financing Activity | 0 | -1,961 | -100 | 0 | 66,459 |
| Financing Cash Flow | $92,482 | $-1,815 | $21 | $107 | $66,531 |
| Beginning Cash Position | 82,021 | 82,021 | 82,021 | 82,021 | 70,544 |
| End Cash Position | 148,718 | 45,563 | 59,049 | 68,544 | 82,021 |
| Net Cash Flow | $66,697 | $-36,458 | $-22,972 | $-13,477 | $11,477 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,422 | -34,450 | -22,882 | -13,555 | -52,824 |
| Capital Expenditure | -321 | -193 | -111 | -29 | -2,230 |
| Free Cash Flow | -51,743 | -34,643 | -22,993 | -13,584 | -55,054 |